Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 10 de 10
Filter
Add more filters










Publication year range
1.
Clin Exp Allergy ; 38(10): 1590-605, 2008 Oct.
Article in English | MEDLINE | ID: mdl-18665843

ABSTRACT

BACKGROUND: Existing treatments for asthma are not effective in all patients and disease exacerbations are common, highlighting the need for increased understanding of disease mechanisms and novel treatment strategies. The leukotriene pathway including the enzyme responsible for arachidonic acid release from cellular phospholipids, cPLA(2)alpha, is a major contributor to asthmatic responses and an attractive target in asthma therapies. OBJECTIVE: The study reported here investigates (a) the differential effects of in vitro exposure of peripheral blood mononuclear cells (PBMCs) to allergen between asthma and healthy subjects, and (b) the contribution of cPLA(2)alpha to these differences in gene expression. METHODS: In vitro responses of asthma (N=26) and healthy (N=11) subject PBMC samples to allergen stimulation in the presence and absence of cPLA(2)alpha inhibition or 5-lipoxygenase inhibition were compared at the gene expression level using oligonucleotide arrays and at the protein level using ELISA. RESULTS: Subject samples within both asthma and healthy groups showed allergen-dependent cytokine production and allergen-dependent gene expression changes, although transcriptional profiling identified 153 genes that were modulated significantly differently by allergen between asthma and healthy subjects. Among these were genes previously associated with asthma, but the majority (about 80%) have not previously been associated with asthma. CONCLUSIONS: Transcriptional profiling elucidated novel gene expression differences between the asthmatic and healthy subject samples. Although 5-lipoxygenase inhibition did not significantly affect allergen-modulated gene expression, the inhibition of cPLA(2)alpha activity affected many of the allergen-dependent, asthma-associated gene expression changes.


Subject(s)
Allergens/immunology , Asthma/immunology , Group IV Phospholipases A2/antagonists & inhibitors , Group IV Phospholipases A2/immunology , Leukocytes, Mononuclear/immunology , Adult , Allergens/metabolism , Arachidonic Acid/metabolism , Asthma/enzymology , Asthma/genetics , Benzoates/pharmacology , Cytokines/immunology , Cytokines/metabolism , Female , Gene Expression Profiling , Group IV Phospholipases A2/metabolism , Humans , Leukocytes, Mononuclear/drug effects , Leukocytes, Mononuclear/enzymology , Male , Middle Aged , Sulfonamides/pharmacology
2.
Pharmacogenomics J ; 6(2): 141-52, 2006.
Article in English | MEDLINE | ID: mdl-16402082

ABSTRACT

Accumulating evidence in animal models and human asthma support a central role for IL-13 signaling in disease pathogenesis. In order to identify asthma and therapy associated genes, global transcriptional changes were monitored in mouse lung following antigen challenge (ovalbumin (OVA)), either alone or in the presence of a soluble IL-13 antagonist. Changes in whole lung gene expression after instillation of mIL-13 were also measured both in wild type and STAT6 deficient mice. A striking overlap in the gene expression profiles induced by either OVA challenge or mIL-13 was observed, further strengthening the relationship of IL-13 signaling to asthma. Consistent with results from functional studies, a subset of the OVA-induced gene expression was significantly inhibited by a soluble IL-13 antagonist while IL-13-modulated gene expression was completely attenuated in the absence of STAT6-mediated signaling. Results from these experiments greatly expand our understanding of asthma and provide novel molecular targets for therapy and potential biomarkers of IL-13 antagonism.


Subject(s)
Asthma/genetics , Gene Expression , Lung/drug effects , Animals , Antigens/immunology , Antigens/pharmacology , Asthma/drug therapy , Asthma/immunology , Disease Models, Animal , Gene Expression/drug effects , Gene Expression/immunology , Gene Expression Profiling , Interleukin-13/antagonists & inhibitors , Interleukin-13/immunology , Interleukin-13/pharmacology , Lung/immunology , Lung/metabolism , Mice , Mice, Inbred BALB C , Mice, Knockout , Oligonucleotide Array Sequence Analysis , Ovalbumin/immunology , Ovalbumin/pharmacology , STAT6 Transcription Factor/genetics
4.
J Biol Chem ; 270(48): 28740-50, 1995 Dec 01.
Article in English | MEDLINE | ID: mdl-7499396

ABSTRACT

alpha 4 beta 1 integrin (VLA-4) appears to be unique among the leukocyte integrins in that it can initiate the adhesion of circulating lymphocytes without cellular activation. It is not known how lymphocytes or other cell types maintain constitutive levels of alpha 4 beta 1 integrin activity. The current report describes a monoclonal antibody, 15/7, that recognizes a high affinity or ligand-occupied conformation of beta 1 integrin. Studies with 15/7 revealed that alpha 4 beta 1 integrin-dependent adhesion of leukocytic cell lines is mediated by a population of low affinity receptors that is conformationally responsive to ligand; the 15/7 epitope could be induced by nanomolar concentrations of soluble VCAM-1 or by micromolar concentrations of a peptide derived from the type III connecting segment domain of fibronectin (as ligands for alpha 4 beta 1 integrin). The same receptors were also responsive to adhesion activating reagents, such as Mn2+, activating anti-beta 1 integrin antibodies, and phorbol myristate acetate, which induced the 15/7 epitope directly and/or decreased the concentration of ligand required for epitope induction. In addition to the responsive receptor pool, cells expressed a second population of alpha 4 beta 1 integrin that was conformationally restrained, failing to respond to ligand or to any of the activating reagents. The relative size of the responsive and inactive receptor pools, as well as the affinity of the responsive receptors, represented a stable phenotype of different cell types and played important roles in defining the cells' adhesive capacity and ligand specificity. Similar receptor populations were measured on lymphocyte subsets in whole blood. These studies provide insight into how cells maintain different constitutive levels of alpha 4 beta 1 integrin activity, and how the activity of beta 1 integrin can be modulated by activators of cell adhesion.


Subject(s)
Integrins/metabolism , Monocytes/cytology , Receptors, Lymphocyte Homing/metabolism , Receptors, Very Late Antigen/metabolism , T-Lymphocytes/cytology , Amino Acid Sequence , Animals , Antibodies, Monoclonal/immunology , Cell Adhesion/immunology , Cell Line , Epitopes/immunology , Humans , Integrin alpha4beta1 , Integrins/immunology , Intercellular Adhesion Molecule-1/metabolism , L Cells/immunology , Ligands , Manganese/pharmacology , Mice , Molecular Sequence Data , Monocytes/immunology , Receptors, Lymphocyte Homing/immunology , Receptors, Very Late Antigen/chemistry , Receptors, Very Late Antigen/drug effects , T-Lymphocytes/immunology , Vascular Cell Adhesion Molecule-1/metabolism
8.
Diabetes ; 38 Suppl 1: 136-9, 1989 Jan.
Article in English | MEDLINE | ID: mdl-2535989

ABSTRACT

Human islets of Langerhans were isolated with the principles of collagenase perfusion via the pancreatic duct and gentle dissociation of tissue. The number of islets released was 161 x 10(3), distributed as 76 x 10(3) large (greater than 100-micron) and 85 x 10(3) small (less than 100-micron) islets. Recovery after Ficoll-gradient purification was 61% for the large islets and 42% for the small islets. The final islet volume was 240 microliter, with purity of 70-90% (large islets) and 20-40% (small islets). Perifusion with glucose elicited a biphasic release of insulin, with the response rising sixfold from basal secretion. Implantation of pure islets under the kidney capsule of normal or streptozocin-induced diabetic nude mice resulted in human C-peptide secretion and partial or complete reversal of hyperglycemia, confirmed by histological recovery. The data show that these methods provide large quantities of viable purified human islets.


Subject(s)
Islets of Langerhans/cytology , Microbial Collagenase/metabolism , Pancreas/cytology , Adult , Animals , C-Peptide/metabolism , Cell Separation/methods , Cell Survival , Humans , Mice , Mice, Nude
9.
Development ; 101(4): 847-56, 1987 Dec.
Article in English | MEDLINE | ID: mdl-3141125

ABSTRACT

Chick embryo neural retinal cells transdifferentiate extensively into lens cells when cultured in Eagle's MEM containing horse and fetal calf sera (FHMEM). Such cultures express elevated levels of pp60c-src-associated tyrosine kinase activity relative to parallel cultures prevented from transdifferentiating by the addition of supplementary glucose (FHGMEM) or replacement of MEM by medium 199 (F199). Northern blotting and in vitro translation studies suggest that c-src mRNA levels are only slightly higher in late transdifferentiating (FHMEM) cultures as compared to parallel blocked (FHGMEM or F199) cultures. By immunocytochemical staining, we show that pp60c-src protein is largely localized in cell groups undergoing conversion into lens (i.e. expressing delta crystallin) in late FHMEM cultures. Initial studies of pp60c-src in chick lens tissues during development indicate that higher kinase activity is found in the epithelial cells relative to mature lens fibres. Thus pp60c-src may be expressed both during the differentiation of lens cells in vivo and during the transdifferentiation of neural retina cells into lens in vitro.


Subject(s)
Retina/embryology , Retroviridae Proteins/metabolism , Animals , Cell Differentiation , Cells, Cultured , Chick Embryo , Immunohistochemistry , Lens, Crystalline/embryology , Oncogene Protein pp60(v-src) , Protein Biosynthesis , Protein Kinases/metabolism
10.
Curr Eye Res ; 3(5): 729-35, 1984 May.
Article in English | MEDLINE | ID: mdl-6734254

ABSTRACT

Delta crystallin has hitherto been considered specific to reptiles and birds. Evidence presented in this paper suggests that a major lens protein in adult river lampreys (Lampetra fluviatilis) is related to chick delta crystallin. Both are of similar size (Mr 45-50,000), and the lamprey protein cross-reacts with antibodies against chick delta crystallin in immunodiffusion, immunoelectrophoretic and immunoblotting tests. However, the charge properties and V8 proteolytic fragment patterns of the lamprey protein are markedly different from those of avian and reptilian delta crystallins. Preliminary evidence on the occurrence of delta-related DNA sequences in the genomes of all vertebrates examined, is also discussed.


Subject(s)
Crystallins/genetics , Fishes/genetics , Lampreys/genetics , Reptiles/genetics , Species Specificity , Animals , Birds/genetics , Crystallins/analysis , Electrophoresis, Polyacrylamide Gel
SELECTION OF CITATIONS
SEARCH DETAIL
...